Vijaya Diagnostic Centre Limited completed the acquisition of P H Diagnostic Centre Private Limited.
December 21, 2023
Share
Vijaya Diagnostic Centre Limited (NSEI:VIJAYA) entered into Share Purchase agreement to acquire P H Diagnostic Centre Private Limited for INR 1.3 billion on December 19, 2023. The del has been approved by board of directors of Vijaya Diagnostic Centre Limited. As of FY 2022-23, P H Diagnostic Centre reported turnover of approximately INR 420 million. The deal is expected to be completed in approximately one month, subject to the completion of Conditions Precedent and other closing actions as per the SPA.
Vijaya Diagnostic Centre Limited (NSEI:VIJAYA) completed the acquisition of P H Diagnostic Centre Private Limited on December 21, 2023. Siddharth Mody, Rahul Deodhar, Alister Sequeira and Prakhar Sharma of J. Sagar Associates acted as the legal advisors to Vijaya Diagnostic Centre Limited (NSEI:VIJAYA). Prem Rajani, Amish Shroff and Karen Issac of Rajani Associates acted as legal advisors to P H Diagnostic Centre and its promoter shareholders.
Vijaya Diagnostic Centre Limited is an India-based company. The Company is engaged in the business of providing comprehensive range of diagnostic services, spanning pathological investigations, basic and high-end radiology, nuclear medicine, and related healthcare services. The Company operates through the Diagnostic Services segment. Its services include clinical pathology, microbiology, hematology, serology, histopathology, cytogenetics, biochemistry, molecular diagnostics, computerized tomography (CT) scan, magnetic resonance imaging (MRI) scan, ultrasound, x-ray, cardiology, gastroenterology, nuclear medicine, pet CT, and MRI -3t. It operates approximately 121 diagnostic centers in 20 cities spread across India.